Media Center
Press Releases

Press Releases

24 Feb 15
Alzheimer’s Disease Treatment Pipeline Remains Large Despite 95% Attrition Rate, says GBI Research

While drug candidates for Alzheimer’s Disease (AD) fail at a much higher rate than the pharmaceutical industry average, the total number of active drugs in the AD treatment pipeline is relatively large at 583, implying a high level of commercial interest.

Read post
29 Jan 15
Ovarian Cancer Treatment Market in Asia-Pacific to Undergo Modest Growth by 2020, says GBI Research

The Asia-Pacific (APAC) therapeutics market for Ovarian Cancer (OC) will undergo a modest rise in value, from $294.3 million in 2013 to $417.6 million by 2020, at a Compound Annual Growth Rate (CAGR) of 5.1%.

Read post
22 Jan 15
Colorectal Cancer Treatment Market Value to Hit $9.4 Billion by 2020, says GBI Research

The value of the Colorectal Cancer (CRC) therapeutics market will increase moderately, from $8.3 billion in 2013 to $9.4 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 1.8%.

Read post
08 Jan 15
European Aesthetic Lasers and Energy Devices Market Value to Reach $258.6 Million by 2020

The European aesthetic lasers and energy devices market across five major countries (Germany, France, Italy, the UK and Spain) was valued at $166.1 million in 2013 and will expand at a Compound Annual Growth Rate (CAGR) of 6.5% to reach $258.6 million by 2020.

Read post
06 Jan 15
Type 2 Diabetes Treatment Market Value in Asia-Pacific to Hit $10.5 Billion by 2020

The type 2 diabetes treatment market in Asia-Pacific (APAC) will rise in value from an estimated $6.5 billion in 2013 to $10.5 billion by 2020, representing a modest Compound Annual Growth Rate (CAGR) of 7.1%.

Read post